Full professor of Medicine, Director, Interventional Cardiology
Montreal Heart Institute/ Univeristy of Montreal, Quebec, Canada
Dr. Jean-François Tanguay is Director of the Interventional Cardiology Division at the MHI and Clinical Cardiologist, with more than 25 years of experience in the field. .
He served as President of the Canadian Interventional Cardiology Association and as Director of the Interventional Cardiology Montreal Symposium (2004-2015). He was Co-Chair of the CCS Anti Platelet Guidelines Committee and their guidelines’ recommendations were published in the Canadian Journal of Cardiology in 2011, 2013, and 2018.
His research is focused on understanding the interactions between platelets, leukocytes and endothelial cells in order to improve vascular healing. With his colleagues at MHI, he performed the first coronary implantation of a drug-eluting bioresorbable scaffold (ABSORBTM) in North-America.
Dr. Tanguay has written more than 250 papers in peer-reviewed journals and more than 250 abstracts & posters.
No relationships to disclose
Long-Term BVS Results in ACS and Chronic CAD
Sunday, March 10, 2024
8:56 AM – 9:04 AM ET
Panel Discussion | DCB for Coronary Applications
Sunday, March 10, 2024
9:04 AM – 9:20 AM ET
Panel Discussion | Parade of DCB Programs and Technologies
Sunday, March 10, 2024
10:00 AM – 10:15 AM ET
Panel Discussion: Will DCB Play a Role for Coronary Application in the US?
Sunday, March 10, 2024
10:55 AM – 11:10 AM ET